OVERVIEW
The global autoimmune disease diagnosis market size is projected to reach USD 5.5 billion by 2024, increasing over the forecast period at a CAGR of 7.67%. The increasing prevalence of autoimmune diseases alongside the population, increased access to medical insurance, and increased spending on health care are key factors driving this market’s growth.
TABLE OF CONTENT
1 Global Autoimmune Disease Diagnosis Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Autoimmune Disease Diagnosis Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Autoimmune Disease Diagnosis Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Autoimmune Disease Diagnosis Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Autoimmune Disease Diagnosis Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Autoimmune Disease Diagnosis Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Autoimmune Disease Diagnosis Market – By Product and Service (Market Size – &
million/billion)
8.1 Consumables and Assay Kits
8.2 Instruments
8.3 Services
9 Global Autoimmune Disease Diagnosis Market – By Test Type
9.1 Routine Laboratory Tests
9.2 Inflammatory Markers
9.3 Autoantibodies and Immunologic Tests
9.4 Other
10 Global Autoimmune Disease Diagnosis Market – By Disease
10.1 Rheumatoid Arthritis
10.2 Systemic Lupus Erythematosus
10.3 Thyroiditis
10.4 Scleroderma
10.5 Sjögren’s syndrome
10.6 Other
11 Global Autoimmune Disease Diagnosis Market – By End-User
11.1 Clinical Laboratories
11.2 Hospitals
11.3 Other
12 Global Autoimmune Disease Diagnosis Market – By Geography (Market Size – &
million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global Autoimmune Disease Diagnosis Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global Autoimmune Disease Diagnosis Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Siemens
14.3 Abbott
14.4 Thermo Fisher Scientific
14.5 Danaher
14.6 HYCOR Biomedical
14.7 Euroimmun
14.8 Bio-Rad Laboratories
14.9 Trinity Biotech
14.10 GRIFOLS
14.11 Inova Diagnostics
14.12 Company 11 & more
15 Global Autoimmune Disease Diagnosis Market – Appendix
15.1 Sources
15.2 Abbreviations